Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study.
about
Inhaled therapy in cystic fibrosis: agents, devices and regimensInhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadInhaled Antibiotics for Gram-Negative Respiratory InfectionsThe role of disposable inhalers in pulmonary drug delivery.Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis.The PulmoSphere™ platform for pulmonary drug delivery.Aerosolized antibiotics in cystic fibrosis: an update.Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis.Clinical pharmacokinetics of inhaled antimicrobials.Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
P2860
Q26797450-D5888E38-B157-4B6B-A1CD-479F335F0DB9Q26822988-394C1234-996E-4CE1-A1CF-749104AA9516Q28386160-6DC4B7B4-0CC3-480A-80C0-E45DC5EC012EQ30368417-F098FD6F-AFA5-4647-82F6-CE5ABE431F66Q33755342-BA3A67B6-8DD2-4E05-9DCF-1477CA961A9CQ34297656-0C3ED4B9-CF66-43DD-8F22-FF854098F656Q35768436-F29C2B04-0C86-4A22-8650-C388A82ACA26Q36374382-CE2FFC5F-FD53-4922-9728-B9A89C21893BQ38193170-3D352D66-20E8-464E-8974-E14D0CECC1BBQ38212537-6AE6D7C7-E3FA-4A41-B4F9-85279AC7635DQ38358856-FC076C97-C6E4-44C5-B75D-AD7E7DC7FD5DQ38367260-E68A620C-8025-4BCC-AEB7-D7D928EF7DEAQ38569772-C32F2972-31E0-4AA6-9731-6AFC3A83619CQ47730320-28144E70-5F67-45A6-9305-3CB115E2A300
P2860
Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Inhalation of a dry powder cip ...... thy subjects: a phase I study.
@en
type
label
Inhalation of a dry powder cip ...... thy subjects: a phase I study.
@en
prefLabel
Inhalation of a dry powder cip ...... thy subjects: a phase I study.
@en
P2093
P2860
P1476
Inhalation of a dry powder cip ...... thy subjects: a phase I study.
@en
P2093
Abhishek Gupta
Heino Stass
Heinz Delesen
Johannes Nagelschmitz
Stefan Willmann
Sybille Baumann
P2860
P304
P356
10.1007/S40261-013-0082-0
P577
2013-06-01T00:00:00Z